Question 1

Has Sarah Brickey received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,334 in general payments to Sarah Brickey across 125 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Sarah Brickey did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Sarah Brickey come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	45	$643
Medtronic(2 entities)	8	$160
Novo Nordisk	6	$134
Dexcom, Inc.	7	$131
Xeris Pharmaceuticals, Inc.	7	$129
Ascendis Pharma Endocrinology Inc	5	$113
Insulet Corporation	6	$111
Tolmar, Inc.	4	$107
Tandem Diabetes Care, Inc.	6	$105
BETA Bionics, Inc.	2	$66
Mannkind Corporation	3	$64
Tolmar Pharmaceuticals, Inc.	3	$61
Soleno Therapeutics, Inc.	2	$60
Sanofi-aventis U.S. LLC	2	$59
Rhythm Pharmaceuticals, Inc.	2	$58
Pfizer	3	$52
Neurocrine Biosciences, Inc.	2	$41
Azurity Pharmaceuticals, Inc.	2	$39
Kyowa Kirin, Inc.	2	$39
Ultragenyx Pharmaceutical Inc.	2	$36
Lilly USA, LLC	2	$33
UCB, Inc.	1	$33
Endo Pharmaceuticals Inc.	1	$21
Amphastar Pharmaceuticals, Inc.	1	$20
Lifescan, Inc.	1	$18

Sarah Brickey

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other pediatric endocrinology in Madera